F-star Therapeutics, Inc. FSTX
7.12 +7.12
Day range unavailable
52-week range unavailable
News
benzinga.com Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) jumped 99% to $1.3195 after the company announced an agreement for the distribution of an Avian Influenza A Virus real-time PCR test kit to the…
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session 
seekingalpha.com F-star's Delayed Acquisition Presents A Risky Opportunity FSTX seems undervalued, even at the $7.12 takeover bid. The CFIUS is delaying the closure of the deal, citing review needed to allay US national security concerns.
benzinga.com Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the…- benzinga.com Why Hoth Therapeutics Shares Are Trading Higher By More Than 130%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session Gainers Hoth Therapeutics, Inc. (NASDAQ: HOTH) shares jumped 131.5% to $10.19 after the FDA accepted the IND application for HT-001.
benzinga.com Why Oil-Related Stocks Traded Higher; Here Are 74 Biggest Movers From Yesterday Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares surged 637.6% to close at $2.01 on Monday after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per…
seekingalpha.com F-star Therapeutics: A Merger Arbitrage Opportunity Expected To Close Soon F-star Therapeutics announced in June that they would be acquired by InvoX, causing shares to soar. InvoX is pricing their bid at $7.12 a share; the offer is set to close on the third of August.
zacks.com New Strong Buy Stocks for July 15th GIL, PBR, CVLG, FSTX and CVBF have been added to the Zacks Rank #1 (Strong Buy) List on July 15, 2022.
zacks.com F-star (FSTX) Stock Rises on Buyout Offer From Sino Biopharm Sino Biopharmaceutical, through its wholly-owned subsidiary, is set to acquire F-star (FSTX) for $7.12 per share in cash. The transaction is likely to close by second-half 2022.
benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2022 Upgrades
benzinga.com F-star Therapeutics Shares Are Rallying Today - Read Why invoX Pharma, a wholly-owned subsidiary of Sino Biopharmaceutical Limited, has agreed to acquire F-star Therapeutics Inc (NASDAQ: FSTX) for $7.12 per share. The proposed acquisition values F-star at…
zacks.com Fstar Therapeutics, Inc. (FSTX) Reports Q1 Loss, Tops Revenue Estimates Fstar Therapeutics, Inc. (FSTX) delivered earnings and revenue surprises of 9.52% and 10.91%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the…
benzinga.com Earnings Scheduled For May 10, 2022 Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.- benzinga.com Stocks That Hit 52-Week Lows On Wednesday During Wednesday's trading, 435 companies set new 52-week lows.
zacks.com Fstar Therapeutics, Inc. (FSTX) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Fstar Therapeutics, Inc. (FSTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
benzinga.com Stocks That Hit 52-Week Lows On Tuesday During Tuesday's session, 454 stocks hit new 52-week lows.
seekingalpha.com F-Star Therapeutics, Inc. (FSTX) CEO Eliot Forster On Q4 2021 Results - Earnings Call Transcript F-Star Therapeutics, Inc. (FSTX) CEO Eliot Forster On Q4 2021 Results - Earnings Call Transcript
globenewswire.com F-star Therapeutics to Present at the 32nd Annual Oppenheimer Healthcare Conference CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., March 10, 2022 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing next…- benzinga.com Stocks That Hit 52-Week Lows On Tuesday Tuesday's session saw 729 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 524 stocks hit new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 368 stocks hit new 52-week lows.
globenewswire.com F-star Therapeutics to Host Fourth Quarter and Full-Year 2021 Financial Results Conference Call on March 14, 2022 CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., March 02, 2022 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing next…
seekingalpha.com F-star Therapeutics: Best-In-Class Tetravalent Bispecific Antibody Technology In Cancers The company's unique selling proposition is its novel, tetravalent bispecific antibody platform which has earned validation through partnership deals with big pharma like Merck.
globenewswire.com F-star Therapeutics to Participate in Upcoming Investor Conferences CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Jan. 07, 2022 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing…
globenewswire.com F-star Therapeutics to Present FS222 Trial-in-Progress Update at ESMO Immuno-Oncology Congress 2021 First-in-Human Study of Company's CD137/PD-L1 Tetravalent Bispecific Antibody Expands into Tumor Specific Indications First-in-Human Study of Company's CD137/PD-L1 Tetravalent Bispecific Antibody…
zacks.com F-star Therapeutics (FSTX) Sees Hammer Chart Pattern: Time to Buy? F-star Therapeutics (FSTX) has been struggling lately, but the selling pressure may be coming to an end soon.
seekingalpha.com F-star Therapeutics, Inc. (FSTX) CEO Eliot Forster on Q3 2021 Results - Earnings Call Transcript F-star Therapeutics, Inc. (FSTX) CEO Eliot Forster on Q3 2021 Results - Earnings Call Transcript
globenewswire.com F-star Therapeutics to Present at The Society for Immunotherapy of Cancer (SITC) 2021 Conference Dr. Michelle Morrow to present on F-star's Proprietary Bispecific Platform including FS118, our LAG-3/PD-L1 Bispecific
benzinga.com Earnings Scheduled For November 10, 2021 Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.24 per share on revenue of $94.32 million.
globenewswire.com F-star Therapeutics to Present at H.C. Wainwright 23rd Annual Global Investment Conference CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing next…
seekingalpha.com F-star Therapeutics, Inc. (FSTX) CEO Eliot Forster on Q2 2021 Results - Earnings Call Transcript F-star Therapeutics, Inc. (FSTX) CEO Eliot Forster on Q2 2021 Results - Earnings Call Transcript- benzinga.com Earnings Scheduled For August 12, 2021 Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter.
zacks.com Why F-star Therapeutics (FSTX) Might Surprise This Earnings Season F-star Therapeutics (FSTX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
zacks.com 5 Drug/Biotech Stocks Set to Outpace Q2 Earnings Estimates Let us take a look at some drug/biotech stocks - FSTX, HALO, KNTE, RUBY and SPRB - that are poised to beat on second-quarter earnings.- benzinga.com Stocks That Hit 52-Week Lows On Tuesday During Tuesday's morning session, 216 companies made new 52-week lows.
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For July 8, 2021
- benzinga.com 60 Biggest Movers From Yesterday Gainers Big Rock Partners Acquisition Corp. (NASDAQ: BRPA) shares jumped 88% to settle at $36.08 on Thursday.
- benzinga.com 38 Stocks Moving In Thursday's Mid-Day Session Gainers Newegg Commerce Inc. (NASDAQ: NEGG) shares jumped 30% to $12.03.
- benzinga.com Stocks That Hit 52-Week Lows On Monday Monday morning saw 78 companies set new 52-week lows.
- benzinga.com 70 Biggest Movers From Friday Gainers InnSuites Hospitality Trust (NYSE: IHT) shares gained 43.4% to close at $3.50 on Friday.
benzinga.com Mid-Afternoon Market Update: Dow Surges Over 200 Points; ChemoCentryx Shares Drop Toward the end of trading Friday, the Dow traded up 0.62% to 34,761.24 while the NASDAQ rose 0.95% to 13,762.12. The S&P also rose, gaining 0.74% to 4,232.81.- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
- benzinga.com 56 Stocks Moving In Friday's Mid-Day Session Gainers InnSuites Hospitality Trust (NYSE: IHT) shares jumped 77% to $4.321.
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For April 16, 2021
- benzinga.com Stocks That Hit 52-Week Highs On Thursday Thursday morning saw 23 companies set new 52-week highs.